Since circulating adiponectin levels are inversely proportional to adipose tissue mass, they have been shown to protect against the development of other obesity-related disorders, including metabolic syndrome, diabetes, cardiovascular disease, and cancers [93]. The gene discussed is ADIPOQ; the disease is cancer.